Charles Patrick France

Affiliations: 
Pharmacology University of Texas Health Science Center at San Antonio, San Antonio, TX, United States 
Area:
Behavioral pharmacology
Google:
"Charles France"
Mean distance: 15.11 (cluster 19)
 
SNBCP
Cross-listing: Chemistry Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Maguire DR, France CP. (2023) Daily methocinnamox treatment dose-dependently attenuates fentanyl self-administration in rhesus monkeys. Neuropharmacology. 243: 109777
Hiranita T, Ho NP, France CP. (2023) . The Journal of Pharmacology and Experimental Therapeutics
Flynn SM, France CP. (2023) Effects of Gabapentinoids on Heroin-Induced Ventilatory Depression and Reversal by Naloxone. Acs Pharmacology & Translational Science. 6: 519-525
Maguire DR, France CP. (2023) Behavioral pharmacology of methocinnamox: A potential new treatment for opioid overdose and opioid use disorder. Journal of the Experimental Analysis of Behavior
Carey LM, Maguire DR, France CP. (2023) Effects of Δ⁹-tetrahydrocannabinol (THC), cannabidiol (CBD), and THC/CBD mixtures on fentanyl versus food choice in rhesus monkeys. Drug and Alcohol Dependence. 244: 109787
Gerak LR, France CP. (2022) Attenuation of the positive-reinforcing effects of ultra-potent fentanyl analogs, along with those of fentanyl and heroin, during daily treatment with methocinnamox (MCAM) in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics
Gerak LR, Maguire DR, Cami-Kobeci G, et al. (2022) OREX-1038: a potential new treatment for pain with low abuse liability and limited adverse effects. Behavioural Pharmacology. 33: 377-394
Maguire DR, France CP. (2022) Effects of daily methocinnamox treatment on fentanyl self-administration in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics
Gray RA, Heal DJ, Maguire DR, et al. (2022) Preclinical assessment of the abuse potential of purified botanical cannabidiol: self-administration, drug discrimination, and physical dependence. The Journal of Pharmacology and Experimental Therapeutics
Flynn SM, France CP. (2021) . The Journal of Pharmacology and Experimental Therapeutics
See more...